• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】56876

【品名】(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-15-({(2R,3S)-3-{[(benzyloxy)carbonyl]amino}-2-[(benzyloxy)methoxy]-3-phenylpropanoyl}oxy)-9-{[(benzyloxy)carbonyl]oxy}-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate

【CA登记号】

【 分 子 式 】C64H67NO18

【 分 子 量 】1138.23192

【元素组成】C 67.53% H 5.93% N 1.23% O 25.3%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(I)

The hydrogenation of the protected taxol derivative (I) with H2 over Pd/C in aqueous THF in the presence of HCl gives the 3'-amino-taxol derivative (II), which is N-benzoylated by means of benzoyl chloride (III) and TEA to provide the target paclitaxel.

1 McChesney, J.D.; Zygmunt, J. (NaPro BioTherapeutics, Inc.); Two-step conversion of protected taxane ester to paclitaxel. WO 0285878 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 56876 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-15-({(2R,3S)-3-{[(benzyloxy)carbonyl]amino}-2-[(benzyloxy)methoxy]-3-phenylpropanoyl}oxy)-9-{[(benzyloxy)carbonyl]oxy}-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate C64H67NO18 详情 详情
(II) 10729 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate C40H47NO13 详情 详情
(III) 10463 Benzoyl chloride 98-88-4 C7H5ClO 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The hydrogenation of the protected taxol derivative (I) with H2 over Pd/C in aqueous THF gives the 3'-amino-2'-O-Bom protected taxol derivative (II), which is N-benzoylated by means of benzoyl anhydride (III) to provide the 2'-O-Bom protected taxol (IV). Finally this compound is deprotected by hydrogenation with H2 over Pd/C in THF/water in the presence of HCl or H2SO4 to afford the target paclitaxel.

1 McChesney, J.D.; Zygmunt, J. (NaPro BioTherapeutics, Inc.); Three-step conversion of protected taxane ester to paclitaxel. WO 0285879 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 56876 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-15-({(2R,3S)-3-{[(benzyloxy)carbonyl]amino}-2-[(benzyloxy)methoxy]-3-phenylpropanoyl}oxy)-9-{[(benzyloxy)carbonyl]oxy}-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate C64H67NO18 详情 详情
(II) 56877 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-15-({(2R,3S)-3-amino-2-[(benzyloxy)methoxy]-3-phenylpropanoyl}oxy)-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate C48H55NO14 详情 详情
(III) 56878 1-phenylvinyl benzoate C15H12O2 详情 详情
(IV) 10747 (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-(benzoylamino)-2-[(benzyloxy)methoxy]-3-phenylpropanoyl]oxy)-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate C55H59NO15 详情 详情
Extended Information